The Proteome of Human Brain After Ischemic Stroke
Authors:
- Anna RosellARAnna Rosell
- Nuria ColoméNCNuria Colomé
- Mar Hernández-GuillamonMHMar Hernández-Guillamon
- Teresa García-BerrocosoTGTeresa García-Berrocoso
- Marc RiboMRMarc Ribo
- Alberto AlcazarAAAlberto Alcazar
- Arantxa Ortega-AznarAOArantxa Ortega-Aznar
- Matilde SalinasMSMatilde Salinas
- Francesc CanalsFCFrancesc Canals
- Joan MontanerJMJoan Montaner
- 1 November 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 69 (11) , 1105-1115
Abstract
Although stroke is among the most common causes of death and chronic disability worldwide, the proteome of the ischemic human brain remains unknown. Only a few studies have investigated the ischemic brain proteome in rodent stroke models. We performed aproteomic study of the human brain after ischemic stroke usinga 2-dimensional differential gel electrophoresis-based proteomic approach. In brain samples from 6 deceased stroke patients and 3 control subjects, there was an average of 1,442 ± 231 protein spots in the gels. Changes of at least 1.5-fold in the relative expression of 132 protein spots between different cerebral areas (infarct core, peri-infarct, and contralateral tissue) were identified (p < 0.05); 39 of these were successfully identified by matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Among the identified protein spots, we validated the results of 10 proteins by Western blot and determined the cellular localization in brain parenchyma for 3 of the identified proteins: dihydropyrimidinase-related protein 2, vesicle-fusing ATPase, and Rho dissociation inhibitor 1. These results contribute to understanding the processes that follow cerebral ischemia; moreover, some of the identified proteins may be therapeutic targets or biologic markers for determining the diagnosis and prognosis of stroke.Keywords
This publication has 34 references indexed in Scilit:
- Proteomic Analysis of Neonatal Mouse Brain: Evidence for Hypoxia- and Ischemia-Induced Dephosphorylation of Collapsin Response Mediator ProteinsJournal of Proteome Research, 2008
- Multiphasic roles for matrix metalloproteinases after strokeCurrent Opinion in Pharmacology, 2008
- Contribution of oncoproteomics to cancer biomarker discoveryMolecular Cancer, 2007
- RhoGDI: multiple functions in the regulation of Rho family GTPase activitiesBiochemical Journal, 2005
- Proteins in Human Brain Cortex Are Modified by Oxidation, Glycoxidation, and LipoxidationJournal of Biological Chemistry, 2005
- A Novel Class of Fusion Polypeptides Inhibits ExocytosisMolecular Pharmacology, 2005
- ApoC‐I and ApoC‐III as potential plasmatic markers to distinguish between ischemic and hemorrhagic strokeProteomics, 2004
- Matrix metalloproteinase‐2 (MMP‐2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP‐ribose) polymerase (PARP) in vitroThe FASEB Journal, 2004
- Protection by bilobalide of the ischaemia‐induced alterations of the mitochondrial respiratory activityFundamental & Clinical Pharmacology, 2000
- Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorderMolecular Psychiatry, 2000